iopromide has been researched along with Neoplasms in 12 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Excerpt | Relevance | Reference |
---|---|---|
"Sixty patients with different malignant tumors were randomized into 4 different PET/CT protocols." | 2.72 | Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging. ( Aschoff, P; Bares, R; Beyer, T; Brechtel, K; Claussen, CD; Eschmann, SM; Klein, M; Mueller, M; Pfannenberg, AC; Vogel, M, 2006) |
"27% patients had colon cancer, 18% lung cancer." | 1.42 | Contrast enhanced chest-MDCT in oncologic patients. Prospective evaluation of the prevalence of incidental pulmonary embolism and added value of thin reconstructions. ( Colombo, B; Cornalba, G; Flor, N; Lombardi, MA; Luciani, A; Tresoldi, S, 2015) |
"VCT shows the vessel architecture of tumors and animals with greater detail and plasticity than has previously been achieved, and is superior to contrast-enhanced magnetic resonance (MR) angiography." | 1.32 | Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis. ( Bock, M; Fink, C; Fusenig, NE; Greschus, S; Kiessling, F; Lichy, MP; Moll, J; Mueller, MM; Semmler, W; Traupe, H; Vosseler, S, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 9 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Terrenato, I | 1 |
Sperati, F | 1 |
Musicco, F | 1 |
Pozzi, AF | 1 |
di Turi, A | 1 |
Caterino, M | 1 |
de Lutio di Castelguidone, E | 1 |
Setola, SV | 1 |
Bellomi, M | 1 |
Neumaier, CE | 1 |
Conti, L | 1 |
Cigliana, G | 1 |
Merola, R | 1 |
Antenucci, A | 1 |
Orlandi, G | 1 |
Giordano, A | 1 |
Barba, M | 1 |
Canitano, S | 1 |
Wang, S | 1 |
Wang, H | 1 |
Song, C | 1 |
Li, Z | 1 |
Wang, Z | 1 |
Xu, H | 1 |
Yu, W | 1 |
Peng, C | 1 |
Li, M | 1 |
Chen, Z | 1 |
Verburg, FA | 2 |
Apitzsch, J | 1 |
Lensing, C | 1 |
Kuhl, CK | 2 |
Pietsch, H | 2 |
Mottaghy, FM | 2 |
Behrendt, FF | 2 |
Cicin, I | 1 |
Erdogan, B | 1 |
Gulsen, E | 1 |
Uzunoglu, S | 1 |
Sut, N | 1 |
Turkmen, E | 1 |
Kodaz, H | 1 |
Ustundag, S | 1 |
Tresoldi, S | 1 |
Flor, N | 1 |
Luciani, A | 1 |
Lombardi, MA | 1 |
Colombo, B | 1 |
Cornalba, G | 1 |
Scialpi, M | 1 |
Palumbo, I | 1 |
Gravante, S | 1 |
Buresta, T | 1 |
D'Andrea, A | 1 |
Pierotti, L | 1 |
Palumbo, B | 1 |
Sun, JS | 1 |
Park, KJ | 1 |
Kang, DK | 1 |
Lee, JH | 1 |
Kim, J | 1 |
Moon, HJ | 1 |
Cho, A | 1 |
Yun, M | 1 |
Lee, JD | 1 |
Kang, WJ | 1 |
Rebière, M | 1 |
Palmowski, M | 1 |
Krohn, T | 1 |
Kiessling, F | 1 |
Greschus, S | 1 |
Lichy, MP | 1 |
Bock, M | 1 |
Fink, C | 1 |
Vosseler, S | 1 |
Moll, J | 1 |
Mueller, MM | 1 |
Fusenig, NE | 1 |
Traupe, H | 1 |
Semmler, W | 1 |
Brechtel, K | 1 |
Klein, M | 1 |
Vogel, M | 1 |
Mueller, M | 1 |
Aschoff, P | 1 |
Beyer, T | 1 |
Eschmann, SM | 1 |
Bares, R | 1 |
Claussen, CD | 1 |
Pfannenberg, AC | 1 |
Vogel, WV | 1 |
van Dalen, JA | 1 |
Oyen, WJ | 1 |
4 trials available for iopromide and Neoplasms
Article | Year |
---|---|
Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.
Topics: Adolescent; Adult; Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Iohexol; Italy; | 2018 |
Body surface area adapted iopromide 300 mg/ml versus 370 mg/ml contrast medium injection protocol: influence on quantitative and clinical assessment in combined PET/CT.
Topics: Algorithms; Body Surface Area; Contrast Media; Dose-Response Relationship, Drug; Female; Humans; Ima | 2013 |
Multiphase CT scanning and different intravenous contrast media concentrations in combined F-18-FDG PET/CT: Effect on quantitative and clinical assessment.
Topics: Contrast Media; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Humans; Infusions, | 2012 |
Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging.
Topics: Artifacts; Biotechnology; Contrast Media; Feasibility Studies; Female; Fluorodeoxyglucose F18; Human | 2006 |
8 other studies available for iopromide and Neoplasms
Article | Year |
---|---|
Synthesis of Bi
Topics: Animals; Bismuth; Cell Line, Tumor; Cell Survival; Infrared Rays; Iohexol; Mice; Nanostructures; Neo | 2019 |
Incidence of contrast-induced nephropathy in hospitalised patients with cancer.
Topics: Adult; Contrast Media; Female; Humans; Incidence; Inpatients; Iohexol; Kidney Diseases; Male; Middle | 2014 |
Contrast enhanced chest-MDCT in oncologic patients. Prospective evaluation of the prevalence of incidental pulmonary embolism and added value of thin reconstructions.
Topics: Adult; Aged; Aged, 80 and over; Colonic Neoplasms; Contrast Media; False Negative Reactions; False P | 2015 |
FDG PET and Split-Bolus Multi-Detector Row CT Fusion Imaging in Oncologic Patients: Preliminary Results.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Iop | 2016 |
CT findings in patients with pericardial effusion: differentiation of malignant and benign disease.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Chi-Square Distribution; Contrast Media; Diagnosis, Differen | 2010 |
Supraclavicular lymph nodes detected by 18F-FDG PET/CT in cancer patients: assessment with 18F-FDG PET/CT and sonography.
Topics: Adult; Aged; Biopsy, Fine-Needle; Clavicle; Contrast Media; Diagnosis, Differential; Female; Fluorod | 2012 |
Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis.
Topics: Animals; Barium Sulfate; Histological Techniques; Iohexol; Iopamidol; Magnetic Resonance Imaging; Mi | 2004 |
Adequate evaluation of image registration in hybrid PET/CT.
Topics: Artifacts; Biotechnology; Contrast Media; Feasibility Studies; Female; Fluorodeoxyglucose F18; Human | 2006 |